Graded against 173,636 supplements + 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, NIH DSLD
Maitake Mushroom
MODERATE EVIDENCESupplementLast updated
AVELOR SUMMARY
Maitake ('dancing mushroom' in Japanese) contains D-fraction beta-glucan that has immune-modulating and anti-cancer research. A 2009 Memorial Sloan Kettering study found maitake D-fraction enhanced NK cell activity by 1.5-2.6x in breast cancer patients. Also shows evidence for blood sugar reduction (improved insulin sensitivity). Grifolan (the specific beta-glucan) activates dendritic cells via dectin-1 receptor. Dose: 3-7mg/day D-fraction extract or 500-1,500mg whole mushroom.
---
*Reviewed by the Dose AI Research Team and Clinical Advisory Board*
*Last updated: 2026-04-06*
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.